News | August 03, 2025
Sandoz to acquire Just–Evotec Biologics facility for $300 million
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Subscribe To Our Newsletter & Stay Updated
